Rapid2 Magnetic Stimulators (Magstim Rapid2, Magstim Super Rapid2, Magstim Super Rapid2 Plus1)— 510(k) K250286

Name: FDA 510(k) clearance K250286
Creator: U.S. Food and Drug Administration
Published: 2025-07-03

Substantially Equivalent

The Magstim Company Limited

FDA 510(k) clearance K250286 for Rapid2 Magnetic Stimulators (Magstim Rapid2, Magstim Super Rapid2, Magstim Super Rapid2 Plus1), Substantially Equivalent on 2025-07-03. Applicant: The Magstim Company Limited. Device class: 2.

Clearance details

Applicant: The Magstim Company Limited
Product code: Code QPL
Device class: Class 2
Regulation: 21 CFR 882.5890
Advisory panel: Neurology
Date received: 2025-01-31
Decision date: 2025-07-03
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Carmarthenshire, GB

Download summary PDF View on FDA.gov ↗

Recent devices under product code QPL

view all

K250309 — BTL-1992025-08-07
K241785 — StarFormer (M008-3T)2025-03-27
K233364 — Axon Therapy2024-01-10
K230014 — MagVenture Pain Therapy: MagPro R30, MagPro R30 with MagOption, MagPro X100, MagPro X100 with MagOption2023-08-25
K210021 — Axon Therapy2021-06-11

More clearances from The Magstim Company Limited

view all

K243869 — Horizon® 3.0 TMS Therapy System (3 models)2025-03-17
K241518 — Horizon® 3.0 TMS Therapy System (3 models)2024-08-30

Data sourced from openFDA. This site is unofficial and independent of the FDA.